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Norepinephrine (NE) released from the nerve terminal of locus coeruleus (LC) neurons
contributes to about 70% of the total extracellular NE in primates brain. In addition, LC
neurons also release NE from somatodendritic sites. Quantal NE release from soma
of LC neurons has the characteristics of long latency, nerve activity-dependency, and
autoinhibition by α2-adrenergic autoreceptor. The distinct kinetics of stimulus-secretion
coupling in somata is regulated by action potential patterns. The physiological significance
of soma and dendritic release is to produce negative-feedback and to down-regulate
neuronal hyperactivity, which consequently inhibit NE release from axon terminal of LC
projecting to many brain areas. Recent discoveries about the LC somatodendritic release
may provide new insights into the pathogenesis of clinic disease involving LC-NE system
dysfunction, and may help developing remedy targeted to the LC area.
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INTRODUCTION
Locus coeruleus (LC) is located in the ventrallateral side of the
fourth ventricle in the pontine, most of which are noradrener-
gic neurons projecting to the cortex, cingulate cortex, amygdala
nucleus, thalamus, hypothalamus, olfactory tubercles, hippocam-
pus, cerebellum, and spinal cord (Swanson and Hartman, 1975).
Norepinephrine (NE) released from the nerve terminal of LC
neurons contributes to about 70% of the total extracellular NE
in primates brain (Svensson, 1987). It plays important roles not
only in arousal, attention, emotion control, and stress (reviewed
in Aston-Jones and Cohen, 2005; Berridge and Waterhouse,
2003; Bouret and Sara, 2005; Nieuwenhuis et al., 2005; Sara and
Devauges, 1989; Valentino and Van Bockstaele, 2008), but also
in sensory information processing (Svensson, 1987). LC directly
modulates the somatosensory information from the peripheral
system. Under the stress condition, LC could completely inhibit
the input from painful stimuli through the descending projection
to the spinal cord (Stahl and Briley, 2004). Dys-regulations of LC
neurotransmission have been suggested to be involved in phys-
ical painful symptoms, attention deficit hyperactivity disorder
(ADHD), sleep/arousal disorder, post-traumatic stress disorder,
depression, schizophrenia, and Parkinson’s disease (reviewed in
Berridge and Waterhouse, 2003; Grimbergen et al., 2009; Mehler
and Purpura, 2009).
Although extensive studies are carried out on functions of
LC neurons in their targeting areas, accumulating evidences sug-
gest that somatodendritic NE release within the LC nucleus also
exerts important functions. The somatodendritic release of LC
was first suspected by an early observation of a NE synthesis
enzyme, dopamine β-hydroxylase, in both soma and dendrites
of LC neurons (Swanson and Hartman, 1975). Microdialysis,
push-pull superfusion and voltammetry are then used to inves-
tigate neurotransmitter release in the LC area in vivo or in brain
slice (reviewed in Singewald and Philippu, 1998). Application of
high potassium solution, field stimulation, or systematic drug all
induce NE release in the LC nucleus but it is hard to differen-
tiate whether NE is released from the somatodendritic sites or
terminals of LC neuron. Recently, we have applied patch-clamp
technique on the somata area of the LC neuron while recording
its quantal NE release simultaneously by carbon fiber electrode
(Huang et al., 2007). Single vesicle release of NE is detected after
depolarization of soma of the LC neurons. In this review, we will
discuss the physiology and characteristics of NE release from LC
somatodendrite.
PHYSIOLOGY OF NE SOMATODENDRITIC RELEASE IN
LC NUCLEUS
AUTOINHIBITION OF NE RELEASE IN LC SOMATA
Adrenergic receptors belong to a family of G-protein coupling
receptors (GPCRs) which are involved in signal transduction
(reviewed in Gilsbach and Hein, 2008). Among them, func-
tional α2A receptors are presented on the somatodendrite of
LC neurons (Norenberg et al., 1997). Therefore, somatoden-
dritic release of NE may be regulated by the interaction of
released NE and α2A receptor. Using voltammetry analysis, sys-
temic application of α2A receptor antagonist is shown to increase
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NE release both from LC nucleus and projecting brain area
(Callado and Stamford, 1999, 2000). Consistently, local perfu-
sion of the α2A receptor agonist clonidine decreases NE in the
LC, whereas the opposite effect is observed with its antagonist
BRL44408 (Pudovkina et al., 2001; Fernandez-Pastor et al., 2005).
With combinedmeasurements of amperometry and patch-clamp,
a doubly enhanced individual quantal release events from LC
somata is achieved upon inhibition of α2A receptor by yohim-
bine (Huang et al., 2007). Thus, NE released from somatoden-
drite inhibits the activity of LC neurons through the activation
of local α2A receptors (Svensson et al., 1975; Cedarbaum and
Aghajanian, 1977) (Figure 1). However, whereas inhibition via
an autoreceptor was originally assumed to involve NE released
from recurrent collaterals (Cedarbaum and Aghajanian, 1977),
our findings identify that TTX blocked ∼20% of total secre-
tion induced by depolarization of the soma, indicating ∼80%
of NE detected in the somatodendrite of LC neuron comes from
LC somata.
INHIBITION OF NEUROTRANSMITTER RELEASE IN PROJECTING
BRAIN AREA
In addition to autoinhibition of release, activation of α2A recep-
tors by NE also hyperpolarizes LC neurons and reduces the firing
rate of LC neurons (Williams et al., 1985). This effect on LC
firing should inhibit the terminal NE release of LC neurons.
It is shown that local administration of a selective NE trans-
porter inhibitor desipramine (DMI) increases NE concentration
in the LC and simultaneously decreases NE level in the cingu-
late cortex (Mateo et al., 1998; Fernandez-Pastor et al., 2005).
Consistently, administration of α2A receptor antagonists into LC
increases NE release in the cortex in a concentration-dependent
manner (Fernandez-Pastor andMeana, 2002). Thus, NE-induced
FIGURE 1 | Schematic representation of physiology of quantal NE
release from somatodendritic sites and terminal in a locus coeruleus
neuron. Action potentials elevate intracellular Ca2+ ([Ca2+i ]) and the release
of NE from the somatodendritic sites of LC neurons. NE, through the
activation of local α2A-adrenoceptors, inhibits LC neurons. Neuropeptides
(i.e., hypocretin) may, via activation of their receptors and PKC, alter
NMDA-induced elevation of [Ca2+]i, which in turn modulates
somatodendritic secretion.
α2A receptor activation in the LC cell body exerts inhibitory tonic
modulation on NE release in its terminal areas as well as in soma.
It is known that stress factors also activate LC neurons
through neurotransmitter receptors located in LC soma, which
consequently modulate NE release in projecting brain area. The
emerging knowledge of how the LC-NE system is regulated by
stressors and determinants of sensitivity of LC neurons to stress-
related neurotransmitters is important for understanding and
alleviating diverse stress-related psychiatric disorders (Valentino
and Van Bockstaele, 2008).
CHARACTERISTICS OF NE RELEASE FROM
SOMATODENDRITIC SITES OF NEURONS IN LOCUS
COERULEUS
ACTION POTENTIAL PATTERN DEPENDENCE
Intracellular recordings of LC neurons in slices from P8–P26
rats show that in response to stimulation, the spontaneous firing
rate increases from (0.3–4Hz) to (15–20Hz) (Williams et al.,
1987). Interestingly, quantal release events from somatodendritic
sites of LC neurons are detected only when the firing rate is high
(15–20Hz) but not low (4Hz) (Berridge and Waterhouse, 2003;
Huang et al., 2007). In contrast, terminal glutamate release of LC
neurons, measured by excitatory post synaptic current (EPSC),
is not affected by the frequency of action potential (Huang et al.,
2007). The high-frequency action potential most likely elevates
the levelof residual calciuminLCsomatawhich leads toNErelease,
as shown in chromaffin cells (Duan et al., 2003). LC neuron firing
is a premise for NE release from terminal. However, it is not con-
sistence with NE release from soma, because we could not observe
quantal release events when the firing frequency is low. Therefore,
stress/stimulus-induced LC hyperactivity in firing may trigger
somatodendriticNErelease,whichexerts auto-inhibitory function
to alleviate thehyperactivity. This negative-feedback viaα2A recep-
tor enables anauto-regulatorymechanismandmayplay important
roles inLCphysiological function.If thesenegative-feedbackmech-
anism is damaged, LC neurons hyperactivity induced by a wide
range of stresses would not be inhibited and, therefore, contribute
to many disorders such as epilepsy, ADHD, sleep/arousal dis-
order, post-traumatic stress disorder, main depression disease,
schizophrenia, Alzheimer’s disease, and Parkinson’s disease et al
(Svensson, 1987; Valentino and Van Bockstaele, 2008).
TIMING OF QUANTAL NE RELEASE FROM SOMATODENDRITES IN LC
Combined amperometry and patch-clamp study of somatic
transmitter secretion from neurons in brain slice preparation
allows accurate measurement of the timing of quantal NE release
following LC neuron firing or depolarization. Compared with the
fast synaptic transmission in the range of milliseconds, the latency
of LC somata release is in the range of seconds, which is 100–1000
times slower (Huang et al., 2007). A plausible explanation for the
dramatic difference between fast glutamate release at synapse and
slow NE release at the somatodendritic region is vesicle positions
with respect to calcium channels. As shown in chromaffin cells,
the channel-vesicle distance is about 10 nm for the fast release, but
>200 nm for the slow release (Elhamdani et al., 1998). The long
latency of NE release from somatodendritic area of LC neurons
may contribute to the delayed autoinhibition on LC neurons.
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COMPARISON TO OTHER SOMATODENDRITIC EXOCYTOSIS
Amperometry measurements have been used to detect quan-
tal monoamine release in different kinds of cell body, such as
chromaffin cell (Chow et al., 1992), leech neuron (Chen et al.,
1995), substance nigra neuron (Jaffe et al., 1998), and dorsal
raphe nucleus (Benzekhroufa et al., 2009). Quantal NE release
from somatodendritic sites of neurons in LC is characterized by
long latency, high sensitivity to frequency of action potential,
calcium-dependence, and low sensitivity to TTX. The quantal size
of NE release from soma of LC neuron is 11.9 fC, correspond-
ing to 37,000 NE molecules (Huang et al., 2007). However, the
quantal size of NE release from terminal of LC neuron could
be 100 times larger. In organotypic rat brainstem slice cultures,
>1 pC quantal events occurred at predominantly axonal release
sites (Chiti and Teschemacher, 2007).
Other monoamines, such as dopamine and 5-HT, are also
released from somatodendritic sites of neurons. Substantia nigra
pars compacta (SNc) neurons release dopamine from somato-
dendrites with charge integrals ranging from a few to several
hundred fC, corresponding to about 14,000 dopamine molecules
on average (Bjorklund and Lindvall, 1975). The dopamine release
in SNc is also Ca2+-dependent. A voltage-gated calcium chan-
nel blocker, Cd2+, blocks the stimulatory effects of glutamate on
quantal dopamine secretion in cultured SNc neurons (Kim et al.,
2008). Interestingly, somatodendritic dopamine release in the
substantia nigra proceeds in a botulinum toxin B resistant path-
way, unlike that of terminal release, suggesting different molecular
players in somata release (Bergquist et al., 2002). In addition, cen-
tral 5-HT exocytosis from cell bodies of raphe nuclei is reported
with a quantal size of ∼34,000 molecules (Benzekhroufa et al.,
2009), similar to what we observe for NE. Further studies on
somata release from various neurons are needed to understand
its physiological roles and characteristics.
NEUROPEPTIDE REGULATION OF NE RELEASE IN LC
LC activity is finely tuned by the convergence of afferent fibers.
Many neurotransmitter receptors are expressed on the cell mem-
brane of LC soma which may control LC functions via regu-
lating LC firing or somatodendritic NE release (Valentino and
Van Bockstaele, 2008). Two of the neuropeptides, orexin and
tachykinins, are shown to regulate NE release in the LC. In
general, neuropeptides play important roles in many essential
physiological functions and behaviors. The success in recording
NE release from LC neurons in brain slices provides a unique
opportunity to investigate the modulation of NE release by neu-
ropeptides at high temporal and spatial resolutions.
HYPOCRETIN (OREXIN)
Hypocretins are neuropeptides in the lateral hypothalamus that
regulate sleep/wake states, feeding behavior, and reward processes
(Ganjavi and Shapiro, 2007). Hypocretin applied in the LC area
depolarizes LC neurons and increases firing rate (Hagan et al.,
1999). At cellular level, high level (1μM) of hypocretin directly
produces dose-dependent somatodendritic NE release, while low
level (0.1μM) of hypocretin notably potentiates NMDA receptor-
mediated somatodendritic release (Chen et al., 2008). This poten-
tiation is blocked by SB 334867, a selective hypocretin receptor
1 antagonist, or bisindolylmaleimide, a specific protein kinase C
(PKC) inhibitor, indicating the involvement of hypocretin recep-
tor 1 and PKC. Consistently, phorbol 12-myristate 13-acetate,
a PKC activator, mimics the hypocretin-induced potentiation.
In addition, hypocretin enhances NMDA-induced intracellular
Ca2+ elevation via activation of hypocretin receptor 1 and PKC,
which mediate hypocretin-potentiated somatodendritic secre-
tion. Thus, hypocretin not only induces NE release in LC somata
at high concentrations, but also potentiates NMDA receptor-
mediated NE release at low concentrations.
TACHYKININS
Tachykinin neuropeptides [substance P (SP), neurokinin A, neu-
rokinin B] and their receptors (NK1, NK2, NK3) are involved
in stress-mechanisms, mood/anxiety regulation, and emotion-
processing (reviewed in Ebner and Singewald, 2007). In freely
moving animals, exposure to forced swimming considerably
enhances the release of both SP and NE in the LC (Ebner and
Singewald, 2007). Administration of a selective NK1R antago-
nist into the LC nucleus potentiates the NE response within
LC nucleus but abolishes the stress-induced increase in terminal
NE release in the medial prefrontal cortex. The NE transmis-
sion in the LC and in the medial prefrontal cortex are also
affected in neurokinin-1-receptor gene knockout (NK1R−/−)
mice (Fisher et al., 2007). The extracellular NE in the frontal
cortex of NK1R−/− mice is two to fourfold greater than that of
NK1R+/+ mice. All these data demonstrate an active interaction
between SP and NE system in the LC.
Several other neuropeptides also affect the firing of LC neu-
rons. Corticotropin-releasing factor increases both the activity of
LC-noradrenergic neurons and the release of NE in a LC termi-
nal region (Page and Abercrombie, 1999). Opioids inhibit firing
by hyperpolarizing LC neurons via μ-opioid receptors (Williams
et al., 1987). Neuropeptide Y and galanin also inhibit firing in LC
neurons (Pieribone et al., 1995; Xu et al., 2005). It remains to be
investigated whether these neuropeptides regulate NE release in
LC neurons.
FUTURE STUDY
The molecular mechanism of LC somatodendritic exocytosis (or
any somatodendritic exocytosis in general) remains largely elu-
sive. Compared with synaptic exocytosis, soma-exocytosis may be
regulated differently in terms of calcium sensitivity, vesicle pools,
and exocytosis machinery. The autoinhibition mediated by α2A
receptor also begs for further investigation. As a GPCR, α2A recep-
tor maymodulate vesicle fusion through Gβγ pathway as shown in
chromaffin cells (Chen et al., 2005). It is well-known that the LC-
NE system is affected by stress and behavior state. SinceNE release
from somata inhibits LC neuron activity, it may serve as a drug
target to modulate LC activity and function. A better understand-
ing of LC somata release may prove useful for drug development
in targeting to LC somatodendrite area specifically.
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